Figure 2

Mean values (±SD) of (A,B) proliferation, (C,D) early apoptosis and (E,F) late apoptosis/necrosis of breast carcinoma cell lines HCC1143 (A,C,E) and HCC1937 (B,D,F) treated with different concentrations of doxorubicin combined with different concentrations of VAE-M.